Vaxleukin-15 Anticancer immunotherapeutics for companion dogs

Interleukin-15

• A type of cytokine that our body's cells use to transmit signals
• It plays an important role in activating the immune system (inducing NK cells and memory T cells)
• It is in the spotlight as a new alternative to chemotherapy as a function of enhancing immune function.

Features and Strong points of Vaxleukin-15

• The world's first anti-cancer immunotherapy drug exclusively for dogs: Design and development based on dog genetic information.
• High productivity: Securing high yield and purity using recombinant protein technology.
• Excellent therapeutic efficacy: Combined with chemotherapy, it has a high therapeutic effect on various carcinomas.

High incidence of pet cancer

Vaxleukin-15 clinical trial results